Presenting the latest research findings from the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis.

A year after announcing plans to leave the World Health Organization, the current administration officially exits the global health group.

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

A new AAN position statement outlines guidelines for switching from branded biologics to biosimilars, while preserving clinical autonomy for physicians.

Headache is a frequent complication after hemorrhagic stroke, with acute symptoms being more common than persistent.

The AAP released its 2026 childhood immunization schedule, maintaining routine vaccine recommendations for several diseases despite revised CDC guidelines.

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.

Common blood biomarkers, like those reflecting inflammatory, vascular, metabolic, and neurodegenerative processes, can predict multimorbidity.

A large retrospective cohort study of over 1 million individuals found no statistically significant difference in Parkinson disease risk between vaccinated and unvaccinated adults. Influenza ...

While safe, external trigeminal nerve stimulation does not show clinical efficacy for ADHD in children and adolescents.